222 related articles for article (PubMed ID: 6312337)
1. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
Ferry DR; Goll A; Glossmann H
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
[TBL] [Abstract][Full Text] [Related]
2. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
3. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
Bellemann P; Ferry D; Lübbecke F; Glossmann H
Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
[TBL] [Abstract][Full Text] [Related]
4. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Lee HR; Roeske WR; Yamamura HI
Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
[TBL] [Abstract][Full Text] [Related]
5. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
Kirley TL; Schwartz A
Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800
[TBL] [Abstract][Full Text] [Related]
6. Identification of putative calcium channels in skeletal muscle microsomes.
Ferry DR; Glossmann H
FEBS Lett; 1982 Nov; 148(2):331-7. PubMed ID: 6295810
[TBL] [Abstract][Full Text] [Related]
7. Are dihydropyridine binding sites voltage sensitive calcium channels?
Miller RJ; Freedman SB
Life Sci; 1984 Mar; 34(13):1205-21. PubMed ID: 6323901
[No Abstract] [Full Text] [Related]
8. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine.
Glossmann H; Ferry DR
Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149
[TBL] [Abstract][Full Text] [Related]
9. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
10. Purified calcium channels have three allosterically coupled drug receptors.
Striessnig J; Goll A; Moosburger K; Glossmann H
FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
[TBL] [Abstract][Full Text] [Related]
11. Binding of [3H]nimodipine to cardiac and smooth muscle membranes.
Janis RA; Maurer SC; Sarmiento JG; Bolger GT; Triggle DJ
Eur J Pharmacol; 1982 Aug; 82(3-4):191-4. PubMed ID: 7128686
[TBL] [Abstract][Full Text] [Related]
12. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
13. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
Williams LT; Tremble P
J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
[TBL] [Abstract][Full Text] [Related]
14. Dihydropyridine [methyl-3H]PN 200-110 binding and myogenesis in intact muscle cells in vitro.
Navarro J
J Neurochem; 1986 Apr; 46(4):1166-9. PubMed ID: 3005507
[TBL] [Abstract][Full Text] [Related]
15. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
16. [3H]nitrendipine labelling of the Ca2+ channel in skeletal muscle.
Fosset M; Jaimovich E; Delpont E; Lazdunski M
Eur J Pharmacol; 1982 Dec; 86(1):141-2. PubMed ID: 6297924
[No Abstract] [Full Text] [Related]
17. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
Goll A; Ferry DR; Glossmann H
FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718
[TBL] [Abstract][Full Text] [Related]
18. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
[TBL] [Abstract][Full Text] [Related]
19. Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranes.
Rampe D; Luchowski E; Rutledge A; Janis RA; Triggle DJ
Can J Physiol Pharmacol; 1987 Jul; 65(7):1452-60. PubMed ID: 2444320
[TBL] [Abstract][Full Text] [Related]
20. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
Gould RJ; Murphy KM; Snyder SH
Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
